FDG-PET provides information on glioma tumor before gene therapy

11/23/2009 | HealthImaging.com

German researchers used the herpes simplex virus type 1 thymidine kinase gene as a marker for the noninvasive in vivo PET imaging of thymidine kinase expression associated with malignant glioma. The researchers also used an F18-labeled tracer to gain information on tumor tissues before gene therapy.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC